Krystal Biotech (KRYS) Enterprise Value (2016 - 2026)
Krystal Biotech (KRYS) reported Enterprise Value of -$823.4 million for Q1 2026, down 33.49% on a YoY basis from -$1.2 billion in Q1 2025, and up 0.53% sequentially from -$827.8 million in Q4 2025.
Krystal Biotech (KRYS) Enterprise Value (2016 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 11 years of Enterprise Value data on file, last reported at -$823.4 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 33.49% year-over-year to -$823.4 million; the trailing twelve-month figure through Mar 2026 stood at -$823.4 million (down 33.49% YoY), and the FY2025 full-year result was -$827.8 million, down 38.54% from the prior year.
- Enterprise Value improved to -$823.4 million in Q1 2026, from -$827.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$350.4 million in Q1 2023 to a low of -$827.8 million in Q4 2025.
- A 5-year average of -$560.0 million and a median of -$559.6 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value increased 19.38% in 2023 and slumped 53.62% in 2024, its largest moves.
- Tracing KRYS's Enterprise Value over 5 years: stood at -$379.2 million in 2022, then sank by 40.35% to -$532.2 million in 2023, then dropped by 12.28% to -$597.5 million in 2024, then sank by 38.54% to -$827.8 million in 2025, then climbed by 0.53% to -$823.4 million in 2026.
- Business Quant data shows KRYS's Enterprise Value at -$823.4 million in Q1 2026, -$827.8 million in Q4 2025, and -$731.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | -823.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -823.41 Mn |
| Dec 31, 2025 | -827.79 Mn |
| Sep 30, 2025 | -731.07 Mn |
| Jun 30, 2025 | -681.99 Mn |
| Mar 31, 2025 | -616.85 Mn |
| Dec 31, 2024 | -597.52 Mn |
| Sep 30, 2024 | -588.32 Mn |
| Jun 30, 2024 | -559.61 Mn |
| Mar 31, 2024 | -538.26 Mn |
| Dec 31, 2023 | -532.18 Mn |
| Sep 30, 2023 | -562.07 Mn |
| Jun 30, 2023 | -477.52 Mn |
| Mar 31, 2023 | -350.39 Mn |
| Dec 31, 2022 | -379.17 Mn |
| Sep 30, 2022 | -394.42 Mn |
| Jun 30, 2022 | -425.57 Mn |
| Mar 31, 2022 | -434.63 Mn |
| Dec 31, 2021 | -438.10 Mn |
| Sep 30, 2021 | -343.09 Mn |
| Jun 30, 2021 | -367.73 Mn |